Tag Archives: Health Canada
CASGEVY: Rethinking Drug Costs Through the Lens of Public Access
Maria Klimenko considers the extent to which the price of innovative treatments like CASGEVY, a type of gene therapy, should reflect not just the cost of development, but also their broader societal impact — and the public healthcare system’s ability to provide equitable access.
Independence, Influence & Power: Canada’s Failed Medicine Pricing Reforms
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).
Feminist Responses to Whole Body Gestational Donation
Nicole Fice questions whether feminist objections to the idea of brain-dead individuals as gestational surrogates can be easily dismissed.
Hepatitis C Treatment Gaps in Prisons
Martha Paynter supports better Hepatitis C treatment coverage in prisons
Conflicts of Interest: The case of Diclectin
Naila Ramji advocates for the importance of clinical trial transparency.
Impact Ethics 